Selective apheresis of C‐reactive protein: A new therapeutic option in myocardial infarction?

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1101|30|1|15-21

ISSN： 0733-2459

Source： JOURNAL OF CLINICAL APHERESIS, Vol.30, Iss.1, 2015-02, pp. : 15-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma C-Reactive Protein and Lipoprotein Levels, and Progression of Coronary Artery Disease after Myocardial Infarction Treated with Thrombolysis

By  

Cardiology, Vol. 104, Iss. 2, 2005-08 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

C-Reactive Protein Levels and Arterial Abnormalities in the Offspring of Patients with Premature Myocardial Infarction

By  

Cardiology, Vol. 100, Iss. 1, 2003-09 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Mechanical Complications after Myocardial Infarction Reliably Predicted Using C-Reactive Protein Levels and Lymphocytopenia

By  

Cardiology, Vol. 99, Iss. 1, 2003-02 ,pp. : 25-31

Karger

Access to resources Recommend Favorite

Association between Electrocardiographic Pattern and Level of C-Reactive Protein in Patients with First Anterior Wall Acute Myocardial Infarction

By  

Cardiology, Vol. 97, Iss. 3, 2002-06 ,pp. : 122-126

Karger

Access to resources Recommend Favorite

Early Use of Beta-Blockers Is Associated with Attenuation of Serum C-Reactive Protein Elevation and Favorable Short-Term Prognosis after Acute Myocardial Infarction

By  

Cardiology, Vol. 99, Iss. 1, 2003-02 ,pp. : 47-53

Karger

Access to resources Recommend Favorite